Employees Retirement System of Texas’s Alexion Pharmaceuticals ALXN Stock Holding History

Employees Retirement System of Texas’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,000	Closed	-$6.43M	–	888
2021 Q2	$6.43M	Hold	35,000	–	–	0.08%	271
2021 Q1	$5.35M	Hold	35,000	–	–	0.07%	301
2020 Q4	$5.47M	Buy	+35,000	New	+$4.5M	0.09%	248
2020 Q2	–	Sell	-38,000	Closed	-$3.41M	–	790
2020 Q1	$3.41M	Buy	+38,000	New	+$3.73M	0.07%	306
2019 Q4	–	Sell	-1,800	Closed	-$176K	–	874
2019 Q3	$176K	Sell	1,800 -7,200	-80%	-$812K	﹤0.01%	836
2019 Q2	$1.18M	Sell	9,000 -1,000	-10%	-$129K	0.02%	742
2019 Q1	$1.35M	Hold	10,000	–	–	0.02%	722
2018 Q4	$974K	Sell	10,000 -20,000	-67%	-$2.36M	0.02%	796
2018 Q3	$4.17M	Hold	30,000	–	–	0.06%	392
2018 Q2	$3.73M	Sell	30,000 -47,000	-61%	-$5.49M	0.05%	443
2018 Q1	$8.58M	Sell	77,000 -29,000	-27%	-$3.47M	0.12%	211
2017 Q4	$12.7M	Sell	106,000 -41,862	-28%	-$5.1M	0.16%	142
2017 Q3	$20.7M	Buy	147,862 +25,484	+21%	+$3.46M	0.27%	80
2017 Q2	$14.9M	Buy	122,378 +50,562	+70%	+$5.88M	0.2%	107
2017 Q1	$8.71M	Sell	71,816 -2,328	-3%	-$300K	0.12%	207
2016 Q4	$9.07M	Buy	74,144 +15,120	+26%	+$1.85M	0.12%	201
2016 Q3	$7.23M	Sell	59,024 -11,914	-17%	-$1.53M	0.1%	249
2016 Q2	$8.28M	Sell	70,938 -20,428	-22%	-$2.9M	0.11%	214
2016 Q1	$12.7M	Sell	91,366 -8,383	-8%	-$1.23M	0.18%	133
2015 Q4	$19M	Sell	99,749 -24,000	-19%	-$4.19M	0.26%	86
2015 Q3	$19.4M	Buy	123,749 +9,071	+8%	+$1.65M	0.28%	75
2015 Q2	$20.7M	Buy	114,678 +48,678	+74%	+$8.4M	0.27%	79
2015 Q1	$11.4M	Buy	66,000 +34,000	+106%	+$6.15M	0.15%	163
2014 Q4	$5.92M	Sell	32,000 -14,000	-30%	-$2.59M	0.08%	306
2014 Q3	$7.63M	Buy	46,000 +12,501	+37%	+$2.05M	0.1%	237
2014 Q2	$5.23M	Buy	33,499 +14,499	+76%	+$2.29M	0.07%	336
2014 Q1	$2.89M	Sell	19,000 -8,000	-30%	-$1.27M	0.04%	485
2013 Q4	$3.59M	Hold	27,000	–	–	0.05%	426
2013 Q3	$3.14M	Sell	27,000 -19,700	-42%	-$2.16M	0.04%	452
2013 Q2	$4.31M	Buy	+46,700	New	+$4.5M	0.05%	357

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Employees Retirement System of Texas's ALXN Position: Q3 2021 in Review

Employees Retirement System of Texas sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 35,000 shares — an estimated $6.43M sold.

Employees Retirement System of Texas first reported a position in ALXN in Q2 2013 and held it in 30 quarters. The position peaked at $20.7M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Employees Retirement System of Texas reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Employees Retirement System of Texas sold 35,000 Alexion Pharmaceuticals shares in Q3 2021, an estimated $6.43M.
Employees Retirement System of Texas first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 30 quarters.
Employees Retirement System of Texas's Alexion Pharmaceuticals position peaked at $20.7M in Q3 2017.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Employees Retirement System of Texas's 13F filing for Q3 2021, filed 12 Nov 2021.